What question did this study set out to answer?

To explore innovations in drug delivery and new therapeutic targets for Parkinson's disease.

February 16, 2026Open Access

Parkinson’s Disease: Conventional Pharmacotherapy, Drug Delivery Innovations, and Emerging Therapeutic Targets

View Full Paper

Ask AI

Bookmark

Authors

Review of pharmacological therapy and continuous infusion approaches in Parkinson's disease, indicating potential new therapeutic targets.

To explore innovations in drug delivery and new therapeutic targets for Parkinson's disease.
Review of current pharmacological therapies including levodopa and dopamine strategies.
Analysis of drug delivery innovations like continuous infusion and dispersible preparations.
Examination of emerging therapeutic targets and their potential impact.
Highlights limitations of current pharmacological therapy for Parkinson’s disease.
Discusses benefits of formulation-driven delivery innovations.
Identifies emerging pathways that could lead to future treatments.

Raina et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Review of pharmacological therapy and continuous infusion approaches in Parkinson's disease, indicating potential new therapeutic targets.